Up until now, only a few studies have examined the role of SEMA6A in cancer biology19, and only one study reported that the extracellular region of SEMA6A could inhibit tumor formation via decreasing VEGF-induced xenograft vascularization20. This evidence concerns the gene SEMA6A and neoplasm.